BioCentury
ARTICLE | Clinical News

Intuniv guanfacine extended release regulatory update

September 28, 2015 7:00 AM UTC

The European Commission approved an MAA from Shire for once-daily Intuniv guanfacine extended release to treat ADHD in patients ages 6-17 for whom stimulants are not suitable, not tolerated or have be...